Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included the 2020 budget plan proposing a mix of healthcare spending cuts and increases; the FDA approving the first immunotherapy regimen for breast cancer; and researchers uncovering how sodium glucose co-transporter-2 inhibitors work.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
Cardiovascular Prevention Guidelines Call for Less Aspirin, More SGLT2s, GLP-1s for Type 2 Diabetes
Giant Study Suggests Apple Watch Accurately Catches Atrial Fibrillation
DECLARE: Dapagliflozin Offers Benefits for Diabetes Patients With Heart Failure
Amarin's High-Dose Fish Oil Pill Cuts Total CV Event Risk 30% in Study
American College of Cardiology 2019
FDA Expands Patient Inclusion Criteria for Cancer Clinical Trials
Dr Janice Mehnert Discusses Including Patients With Comorbidities in Cancer Clinical Trials
Reducing Low-Value Care May Mean Tough Conversations With Stakeholders
Participation in Community Groups Found to Increase Awareness of PrEP
ACCC Annual Meeting & Cancer Center Business Summit
National Comprehensive Cancer Network Annual Conference 2019
Read more about the stories in this podcast:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen